Trials / Completed
CompletedNCT02125981
The Study About the Efficacy of Oral Limaprost After Surgery for Cervical Myelopathy
A Prospective Randomized Double-blinded Clinical Trial About the Efficacy of Oral Limaprost Administration Following Surgery for Cervical Myelopathy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The limaprost alfadex can improve the surgical outcomes in patients with cervical myelopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Limaprost | taking Limaprost α-Cyclodextrin Clathrate 1 Tablets (166.67 μg), three times per day |
| DRUG | Placebo | taking placebo drug |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2022-10-01
- Completion
- 2023-04-01
- First posted
- 2014-04-29
- Last updated
- 2023-04-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02125981. Inclusion in this directory is not an endorsement.